drugset / Trial / NCT01939028

Lymph Node Mapping in Patients With Newly Diagnosed Endometrial Cancer Undergoing Surgery

NCT01939028

Terminated 58 enrolled Case Comprehensive Cancer Center
NaSingle-groupOpen-labelDiagnostic

Summary

This clinical trial studies lymph node mapping in patients with newly diagnosed endometrial cancer undergoing surgery. Lymph node mapping may help in planning surgery to remove endometrial cancer and affected lymph nodes.

Timeline

Start
2013-07
Primary completion
2016-10
Completion
2016-10

Drugs

EvaluationDrugModalityDoseRoute
Subject isosulfan blue Diagnostic / imaging agent Other

Indications